Net Income - Standard Chem & Pharm Co Ltd (TWSE:1720) - Alpha Spread

Standard Chem & Pharm Co Ltd
TWSE:1720

Watchlist Manager
Standard Chem & Pharm Co Ltd Logo
Standard Chem & Pharm Co Ltd
TWSE:1720
Watchlist
Price: 65.1 TWD 0.46% Market Closed
Market Cap: 11.6B TWD
Have any thoughts about
Standard Chem & Pharm Co Ltd?
Write Note

Standard Chem & Pharm Co Ltd
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Standard Chem & Pharm Co Ltd
Net Income Peer Comparison

Comparables:
Y
3705
4746
1789
S
4119
1795

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Standard Chem & Pharm Co Ltd
TWSE:1720
Net Income
NT$1.5B
CAGR 3-Years
19%
CAGR 5-Years
20%
CAGR 10-Years
16%
Y
YungShin Global Holding Corp
TWSE:3705
Net Income
NT$1.5B
CAGR 3-Years
16%
CAGR 5-Years
9%
CAGR 10-Years
5%
Formosa Laboratories Inc
TWSE:4746
Net Income
NT$288.5m
CAGR 3-Years
-45%
CAGR 5-Years
N/A
CAGR 10-Years
2%
ScinoPharm Taiwan Ltd
TWSE:1789
Net Income
NT$495.3m
CAGR 3-Years
14%
CAGR 5-Years
4%
CAGR 10-Years
-6%
S
SCI Pharmtech Inc
TWSE:4119
Net Income
NT$152.4m
CAGR 3-Years
N/A
CAGR 5-Years
-26%
CAGR 10-Years
-5%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Net Income
NT$8.1B
CAGR 3-Years
64%
CAGR 5-Years
63%
CAGR 10-Years
N/A

See Also

What is Standard Chem & Pharm Co Ltd's Net Income?
Net Income
1.5B TWD

Based on the financial report for Jun 30, 2024, Standard Chem & Pharm Co Ltd's Net Income amounts to 1.5B TWD.

What is Standard Chem & Pharm Co Ltd's Net Income growth rate?
Net Income CAGR 10Y
16%

Over the last year, the Net Income growth was 2%. The average annual Net Income growth rates for Standard Chem & Pharm Co Ltd have been 19% over the past three years , 20% over the past five years , and 16% over the past ten years .

Back to Top